ACTEMRA
These highlights do not include all the information needed to use ACTEMRA safely and effectively. See full prescribing information for ACTEMRA. ACTEMRA (tocilizumab) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2010
2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13
HUMAN PRESCRIPTION DRUG LABEL
Dec 23, 2022
Genentech, Inc.
DUNS: 080129000
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
tocilizumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
tocilizumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
tocilizumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
tocilizumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
tocilizumab
Product Details
FDA regulatory identification and product classification information